Matches in SemOpenAlex for { <https://semopenalex.org/work/W1977289984> ?p ?o ?g. }
- W1977289984 endingPage "1074" @default.
- W1977289984 startingPage "1070" @default.
- W1977289984 abstract "Study objective To determine if treatment with inhaled budesonide forte can diminish increased bronchial hyperreactivity and improve symptoms in patients with mitral valve stenosis. Design The study was randomized, double blind, and placebo controlled. Setting Outpatient/university hospital. Patients Twelve subjects, 8 female and 4 male, who qualified for mitral valve replacement. All subjects presented with increased bronchial reactivity to histamine at the time of the study. Interventions Patients received placebo or budesonide forte twice a day (1,200 mg/d) for 6 weeks. During the study, patients were treated with the same doses of diuretics and other medications that could affect bronchial reactivity. Measurements Spirometry, provocative concentration of histamine causing a 20% fall in the FEV1 (PC20H), symptom scores. Results In the treated group, the initial PC20H was 0.82 ± 0.72 mg/mL; in the placebo group 1.39 ±1.3 mg/mL. After 6 weeks of treatment, PC20H was significantly higher (3.07 ± 2.28 mg/mL; p > 0.01) in the budesonide-treated group and remained unchanged in the placebo group (1.49 ± 0.91). Symptom scores were significantly lower after administration of budesonide forte (mean change, 4.0 ± 2.6). Conclusions Six weeks of treatment with budesonide forte significantly decreased bronchial reactivity to histamine and improved symptoms in patients with mitral valve stenosis. To determine if treatment with inhaled budesonide forte can diminish increased bronchial hyperreactivity and improve symptoms in patients with mitral valve stenosis. The study was randomized, double blind, and placebo controlled. Outpatient/university hospital. Twelve subjects, 8 female and 4 male, who qualified for mitral valve replacement. All subjects presented with increased bronchial reactivity to histamine at the time of the study. Patients received placebo or budesonide forte twice a day (1,200 mg/d) for 6 weeks. During the study, patients were treated with the same doses of diuretics and other medications that could affect bronchial reactivity. Spirometry, provocative concentration of histamine causing a 20% fall in the FEV1 (PC20H), symptom scores. In the treated group, the initial PC20H was 0.82 ± 0.72 mg/mL; in the placebo group 1.39 ±1.3 mg/mL. After 6 weeks of treatment, PC20H was significantly higher (3.07 ± 2.28 mg/mL; p > 0.01) in the budesonide-treated group and remained unchanged in the placebo group (1.49 ± 0.91). Symptom scores were significantly lower after administration of budesonide forte (mean change, 4.0 ± 2.6). Six weeks of treatment with budesonide forte significantly decreased bronchial reactivity to histamine and improved symptoms in patients with mitral valve stenosis." @default.
- W1977289984 created "2016-06-24" @default.
- W1977289984 creator A5000042628 @default.
- W1977289984 creator A5011790287 @default.
- W1977289984 creator A5023960478 @default.
- W1977289984 creator A5031566851 @default.
- W1977289984 creator A5044358609 @default.
- W1977289984 creator A5064084880 @default.
- W1977289984 creator A5070893837 @default.
- W1977289984 date "1998-10-01" @default.
- W1977289984 modified "2023-09-25" @default.
- W1977289984 title "Inhaled Corticosteroid Improves Bronchial Reactivity and Decreases Symptoms in Patients With Mitral Stenosis" @default.
- W1977289984 cites W121149184 @default.
- W1977289984 cites W1832566025 @default.
- W1977289984 cites W1855264373 @default.
- W1977289984 cites W1901945304 @default.
- W1977289984 cites W1963966810 @default.
- W1977289984 cites W2003299282 @default.
- W1977289984 cites W2018940868 @default.
- W1977289984 cites W2019395106 @default.
- W1977289984 cites W2029250352 @default.
- W1977289984 cites W2033529475 @default.
- W1977289984 cites W2041179424 @default.
- W1977289984 cites W2059523828 @default.
- W1977289984 cites W2061614070 @default.
- W1977289984 cites W2067660109 @default.
- W1977289984 cites W2077654181 @default.
- W1977289984 cites W2105460778 @default.
- W1977289984 cites W2120241658 @default.
- W1977289984 cites W2171212922 @default.
- W1977289984 cites W2173426336 @default.
- W1977289984 cites W2339133869 @default.
- W1977289984 cites W2341913087 @default.
- W1977289984 cites W2432763970 @default.
- W1977289984 cites W635823640 @default.
- W1977289984 doi "https://doi.org/10.1378/chest.114.4.1070" @default.
- W1977289984 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9792579" @default.
- W1977289984 hasPublicationYear "1998" @default.
- W1977289984 type Work @default.
- W1977289984 sameAs 1977289984 @default.
- W1977289984 citedByCount "9" @default.
- W1977289984 countsByYear W19772899842013 @default.
- W1977289984 countsByYear W19772899842015 @default.
- W1977289984 crossrefType "journal-article" @default.
- W1977289984 hasAuthorship W1977289984A5000042628 @default.
- W1977289984 hasAuthorship W1977289984A5011790287 @default.
- W1977289984 hasAuthorship W1977289984A5023960478 @default.
- W1977289984 hasAuthorship W1977289984A5031566851 @default.
- W1977289984 hasAuthorship W1977289984A5044358609 @default.
- W1977289984 hasAuthorship W1977289984A5064084880 @default.
- W1977289984 hasAuthorship W1977289984A5070893837 @default.
- W1977289984 hasConcept C126322002 @default.
- W1977289984 hasConcept C142724271 @default.
- W1977289984 hasConcept C164705383 @default.
- W1977289984 hasConcept C168563851 @default.
- W1977289984 hasConcept C204787440 @default.
- W1977289984 hasConcept C27081682 @default.
- W1977289984 hasConcept C2776042228 @default.
- W1977289984 hasConcept C2776136866 @default.
- W1977289984 hasConcept C2776804153 @default.
- W1977289984 hasConcept C2776954882 @default.
- W1977289984 hasConcept C2780007028 @default.
- W1977289984 hasConcept C2780333948 @default.
- W1977289984 hasConcept C2781212218 @default.
- W1977289984 hasConcept C3020110884 @default.
- W1977289984 hasConcept C42219234 @default.
- W1977289984 hasConcept C71924100 @default.
- W1977289984 hasConceptScore W1977289984C126322002 @default.
- W1977289984 hasConceptScore W1977289984C142724271 @default.
- W1977289984 hasConceptScore W1977289984C164705383 @default.
- W1977289984 hasConceptScore W1977289984C168563851 @default.
- W1977289984 hasConceptScore W1977289984C204787440 @default.
- W1977289984 hasConceptScore W1977289984C27081682 @default.
- W1977289984 hasConceptScore W1977289984C2776042228 @default.
- W1977289984 hasConceptScore W1977289984C2776136866 @default.
- W1977289984 hasConceptScore W1977289984C2776804153 @default.
- W1977289984 hasConceptScore W1977289984C2776954882 @default.
- W1977289984 hasConceptScore W1977289984C2780007028 @default.
- W1977289984 hasConceptScore W1977289984C2780333948 @default.
- W1977289984 hasConceptScore W1977289984C2781212218 @default.
- W1977289984 hasConceptScore W1977289984C3020110884 @default.
- W1977289984 hasConceptScore W1977289984C42219234 @default.
- W1977289984 hasConceptScore W1977289984C71924100 @default.
- W1977289984 hasIssue "4" @default.
- W1977289984 hasLocation W19772899841 @default.
- W1977289984 hasLocation W19772899842 @default.
- W1977289984 hasOpenAccess W1977289984 @default.
- W1977289984 hasPrimaryLocation W19772899841 @default.
- W1977289984 hasRelatedWork W1811806876 @default.
- W1977289984 hasRelatedWork W2041776764 @default.
- W1977289984 hasRelatedWork W2080656321 @default.
- W1977289984 hasRelatedWork W2092861518 @default.
- W1977289984 hasRelatedWork W2111225968 @default.
- W1977289984 hasRelatedWork W2146830701 @default.
- W1977289984 hasRelatedWork W2162130040 @default.
- W1977289984 hasRelatedWork W2225874130 @default.
- W1977289984 hasRelatedWork W2295504875 @default.
- W1977289984 hasRelatedWork W2340824004 @default.